Novo Nordisk's semaglutide ... will consist of seven studies involving around 8,000 patients and will include a trial specifically looking at whether the drug can reduce cardiovascular disease ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

GSK said that the osteosarcoma designation is supported by data from the phase 2 ARTEMIS-002 study, an open-label trial that is evaluating GSK'227 in patients with relapsed or refractory ...